MarketPeel
Insider Trading Intelligence
MD

Matt Davidson

ADIL
CHIEF DEVELOPMENT OFFICER · ADIAL PHARMACEUTICALS, INC. · CIK 0001741937
FILING MIX · LIFETIME100%/0%
BUYS
6
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jun 2026
HOLDINGS NOW
297,491
AVG SELL PX
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Matt Davidson. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
ADIL · 297,491 shares · as of Jun 12, 2026
074,373148,746223,118297,491SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
FLOW · 6 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
232,417232,417Jun 12, 2026Jun 16, 2026View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
232,417297,491Jun 12, 2026Jun 16, 2026View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,4273,427Jun 11, 2026Jun 16, 2026View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
101.2981,923.428Jun 11, 2026Jun 16, 2026View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
61,64761,647Jun 11, 2026Jun 16, 2026View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,822.131,822.13Jun 11, 2026Jun 16, 2026View →
Other insiders · ADIL
Loading peer insiders…
About this filer
CIK 0001741937
ROLE
Chief Development Officer
PRIMARY
ADIL
COMPANIES
1
ACTIVE SINCE
Jun 2026
MARKETPEEL · /INSIDER/0001741937DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback